SCHEMBL23809299

SCHEMBL23809299

COC1CCN(Cc2cc(C(C)C)c3c(c2)cc(C(=O)O)n3C)CC1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
BCHE P06276 1/20 0.37
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.35
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
ENPP2 Q13822 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
USP2 O75604 1/20 0.34
SSTR5 P35346 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
CCR3 P51677 1/20 0.34
MCHR1 Q99705 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23809293 0.89 MEN1 (0.40) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL23809525 0.86 HRH3 (0.41) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL23809267 0.82 HRH3 (0.43) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL30622488 0.78 KDM4E (0.50) ALDH1A1KDM4EHPGDHSD17B10DRD4
SCHEMBL26590715 0.78 MEN1 (0.38) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL23809265 0.78 PIK3CD (0.39) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL26048075 0.78 ALDH1A1 (0.40) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL23809489 0.77 HSD17B10 (0.46) KMT2AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL23809497 0.75 ALDH1A1 (0.36) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL26037572 0.75 HRH3 (0.39) MEN1KMT2AALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 MEN1 3549/4885KMT2A 824/4885ALDH1A1 2556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.